Compound Summary
Rizatriptan benzoate
Compound Information
Rizatriptan benzoate
Compound Name: | Rizatriptan benzoate |
Compound CID: | 77997 |
Synonyms: | Rizatriptan benzoate 145202-66-0 Maxalt Rizatriptan (benzoate) Maxalt-MLT More... |
Iupac Name: | benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine |
InChI: | InChI=1S/C15H19N5.C7H6O2/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20;8-7(9)6-4-2-1-3-5-6/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3;1-5H,(H,8,9) |
InChIKey: | JPRXYLQNJJVCMZ-UHFFFAOYSA-N |
Canonical Smiles: | CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O |
Isomeric Smiles: | CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O |
Molecular Weight: | 391.5 |
Molecular Formula: | C22H25N5O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Rizatriptan benzoate
Molecular Weight: | 391.5 |
Molecular Formula: | C22H25N5O2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 6 |
Heavy Atom Count: | 29 |
Complexity: | 412 |
Synonyms
Rizatriptan benzoate
| Rizatriptan benzoate | Rizatriptan benzoate |
|---|---|
Rizatriptan benzoate |
145202-66-0 |
Maxalt |
Rizatriptan (benzoate) |
Maxalt-MLT |
MK 462 |
MK-462 |
MK-0462 |
UNII-WR978S7QHH |
2-(5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-1H-INDOL-3-YL)-N,N-DIMETHYLETHANAMINE BENZOATE |
WR978S7QHH |
Rizatriptan Benzoate (Maxalt) |
N,N-Dimethyl-2-5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-ylethylamine benzoate |
2-(5-((1H-1,2,4-triazol-1-yl)methyl)-1H-indol-3-yl)-N,N-dimethylethan-1-amine benzoate |
benzoic acid;N,N-dimethyl-2-5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-ylethanamine |
MK 0462 |
L 705126 |
L 705,126 |
L-705,126 |
Rizatriptan benzoate USAN:USP |
rizatrimptan benzoate |
rizatriptane benzoate |
rizatriptan, benzoate |
MK-462 Benzoate |
SCHEMBL41226 |
MLS001424197 |
CHEBI:8875 |
RIZATRIPTAN BENZOATE SALT |
CHEMBL1201032 |
Rizatriptan benzoate (JAN/USP) |
AMY8935 |
DTXSID20162937 |
RHB-103 |
HMS2051B16 |
HMS2093K08 |
HMS2235M18 |
HMS3369I15 |
HMS3393B16 |
HMS3655K09 |
HMS3715D08 |
HMS3884K21 |
Pharmakon1600-01505189 |
ACT04340 |
BCP02149 |
HY-B0206 |
INT-0008 |
AC-734 |
MFCD00866224 |
NSC758919 |
AKOS015855933 |
AB07521 |
CCG-101039 |
KS-1189 |
NC00289 |
NSC 758919 |
NSC-758919 |
1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, monobenzoate |
3-(2-(Dimethylamino)ethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)indole monobenzoate |
SMR000525252 |
AB0011227 |
DB-015783 |
Rizatriptan benzoate salt, >=98% (HPLC) |
FT-0631171 |
R0107 |
R0181 |
S1607 |
SW197669-2 |
D00675 |
202R660 |
A808337 |
SR-01000763588 |
J-008071 |
J-524222 |
SR-01000763588-3 |
Q27292788 |
Rizatriptan benzoate, European Pharmacopoeia (EP) Reference Standard |
Rizatriptan benzoate, United States Pharmacopeia (USP) Reference Standard |
DIMETHYL-2-(5-1,2,4TRIAZOL-1-YLMETHYL-1H-INDOL-3-YL)-ETHYL-AMINE BENZOATE |
N,N-dimethyl-2-5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-ylethanamine benzoate |
N,N-DIMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOLE-3-ETHANAMINE BENZOATE |
Rizatriptan for system suitability, European Pharmacopoeia (EP) Reference Standard |
Experimental Data
Rizatriptan benzoate
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 10.000000000000000 | umol/L | 16.180000000000000 | 15.920000000000000 | -1.600000000000000 | NS | N2 | 33008901 | Inactive | ||||
| Drosophila melanogaster | 200.000000000000000 | umol/L | 42.220000000000000 | 43.280000000000000 | 2.510000000000000 | NS | MALES | 33008901 | Inactive | ||||
| Drosophila melanogaster | 20.000000000000000 | umol/L | 47.990000000000000 | 49.880000000000000 | 3.930000000000000 | NS | FEMALES | 33008901 | Inactive | ||||
| Caenorhabditis elegans | 100.000000000000000 | umol/L | 16.480000000000000 | 14.550000000000000 | -11.710000000000000 | NS | N2 | 33008901 | Inactive |
Experimental Data Visualization
Rizatriptan benzoate
Statistics Data
Rizatriptan benzoate
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -1.600000000000000 | 1 | 2 | |
| Drosophila melanogaster | 3.930000000000000 | 1 | 2 |
Statistics Data Visualization
Rizatriptan benzoate
